t
GSK plc notified the market of its total voting rights and capital in conformity with FCA Disclosure Guidance and Transparency Rule 5.6.1R. As at 31 October 2025, the Company's issued share capital was 4,315,423,599 shares, with 254,768,344 Ordinary Shares held in Treasury. This resulted in a total of 4,060,655,255 voting rights in the Company, as reported on 3 November 2025.
| Date | 3 Nov 2025 |
| Time | 15:00:01 |
| Category | Capital structure |
| ID | 9662F |
GSK plc
Total Voting Rights and Capital
In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following:
The Company's issued share capital as at 31 October 2025 consisted of 4,315,423,599 shares of 31 ¼ pence each ('Ordinary Shares'), of which 254,768,344 Ordinary Shares were held in Treasury.
Therefore, the total number of voting rights in the Company is 4,060,655,255. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Notifications may be sent to [email protected].
V A Whyte
Company Secretary
3 November 2025